Top Page
Enwave Corp
(ENW)
Enwave Corp (ENW) vs. iShares MSCI Canada ETF (EWC)
Enwave Corp Business Overview & Revenue Model
Enwave Corp Earnings Call Summary
Enwave Corp Financial Statement Overview
| Breakdown | |||||
| TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 8.10M | 8.18M | 11.36M | 23.70M | 26.48M | 32.88M |
| Gross Profit | |||||
| 2.77M | 2.66M | 4.24M | 6.29M | 7.17M | 8.77M |
| EBIT | |||||
| -1.87M | 0.00 | -1.47M | -7.06M | -3.48M | -5.20M |
| EBITDA | |||||
| -780.00K | -1.05M | -334.00K | -1.43M | -2.32M | -5.20M |
| Net Income Common Stockholders | |||||
| -2.05M | -2.40M | -6.51M | -6.93M | -4.13M | -4.44M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 3.99M | 4.76M | 4.17M | 6.20M | 11.79M | 14.71M |
| Total Assets | |||||
| 12.24M | 13.15M | 16.03M | 25.85M | 30.64M | 40.66M |
| Total Debt | |||||
| 1.95M | 1.57M | 1.38M | 2.43M | 1.78M | 2.31M |
| Net Debt | |||||
| -2.03M | -3.19M | -2.79M | -3.77M | -10.01M | -12.40M |
| Total Liabilities | |||||
| 3.61M | 3.73M | 4.47M | 8.22M | 7.65M | 12.31M |
| Stockholders Equity | |||||
| 8.63M | 9.42M | 11.56M | 17.63M | 22.99M | 28.35M |
| Cash Flow | Free Cash Flow | ||||
| 155.00K | 1.17M | -2.56M | -4.96M | -24.00K | -4.94M |
| Operating Cash Flow | |||||
| 203.00K | 1.39M | -2.51M | -2.26M | 2.04M | -4.13M |
| Investing Cash Flow | |||||
| 70.00K | -116.00K | 1.36M | -2.52M | -1.82M | -491.00K |
| Financing Cash Flow | |||||
| -276.00K | -692.00K | -900.00K | -939.00K | -2.93M | 678.00K |
Enwave Corp Technical Analysis
Enwave Corp Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $8.59B | 10.29 | 4.70% | 4.38% | 4.14% | -13.05% | |
60 Neutral | C$42.77M | 354.55 | -10.19% | ― | 89.54% | ― | |
53 Neutral | C$97.08M | ― | -5701.32% | ― | 14.45% | 76.75% | |
49 Neutral | C$15.58M | ― | -525.98% | ― | -24.60% | -11.26% | |
41 Neutral | C$71.24M | ― | -1898.77% | ― | 408.78% | -20.74% |
Enwave Corp Corporate Events
EnWave Corporation reported significant financial growth in its second quarter of 2025, with a substantial increase in revenue driven by machine sales and higher royalty revenues. The company’s gross margin improved significantly due to increased machine sales and royalties, while its adjusted EBITDA turned positive, indicating improved operational efficiency. EnWave also announced several strategic agreements and amendments, expanding its market reach and enhancing its product offerings, which are expected to strengthen its industry positioning and provide new opportunities for growth.
EnWave Corporation has amended its license agreement with Creations Foods, allowing the latter to produce dried cheese snacks for pet treat applications in the United States using EnWave’s REV™ technology. This strategic move aims to capitalize on the growing pet food industry, with Creations Foods already having several confirmed pet treat customers. EnWave is also actively seeking new partners in the pet treat and food industry to expand the use of its technology, as demonstrated by its recent participation in the Pet Food Forum in Kansas City.
EnWave Corporation announced it will release its second-quarter financial results for 2025 on May 21, followed by an investor conference call on May 22. The announcement highlights EnWave’s continued focus on enhancing its market position through its innovative dehydration technology, which offers significant advantages over traditional drying methods. This release is important for stakeholders as it reflects the company’s ongoing efforts to expand its market reach and improve operational efficiency.
EnWave Corporation has received a second progress payment from Procescir S.A. de C.V. for a 120kW Radiant Energy Vacuum machine, which will be used for commercial production of fruit and vegetable products in Mexico. This development includes a two-year toll drying agreement with a leading American healthy snack company, which is expected to significantly enhance EnWave’s royalty portfolio. The company is also preparing to build an additional large-scale REV™ machine to meet future demand, indicating strong growth prospects and reinforcing its position in the drying technology market.
EnWave Corporation has signed an Equipment Purchase Agreement and License Amendment with MicroDried®, a leading U.S.-based producer of premium fruit and vegetable ingredients. The agreement involves the acquisition of a 60kW Radiant Energy Vacuum machine to enhance MicroDried’s production capacity, with an option for an additional machine. The amendment grants MicroDried exclusive rights to use EnWave’s technology for apple ingredient production in specific U.S. states, strengthening its position in the fruit processing industry. This move is expected to support MicroDried’s growth and meet increasing demand for its clean-label ingredients.
EnWave Corporation has entered into a master service agreement with BioTechnique LLC, a pharmaceutical contract manufacturing service provider, to evaluate EnWave’s Radiant Energy Vacuum (REV™) technology as a potential alternative to lyophilization in the biopharmaceutical industry. The collaboration will involve testing liquid products using EnWave’s pilot-scale REV™ machinery, and if successful, BioTechnique may acquire the technology for its own use, potentially enhancing EnWave’s market presence in the pharmaceutical sector.
EnWave Corporation has signed a new royalty-bearing commercial license with Hokkai Yamato Foods Japan, a prominent processed food manufacturer. This agreement allows Hokkai Yamato to use EnWave’s patented REV™ technology for product development and commercial production in Japan. The partnership is expected to enhance Hokkai Yamato’s product offerings and market reach, while EnWave continues to expand its presence in the Japanese market.